Quick Answer
MUSTANG BIO, INC. reported Stockholders Equity of $9.53 million for fiscal year 2025.
MUSTANG BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $9.53M | +346.0% |
| 2024 | -$3.87M | -3248.8% |
| 2023 | $123.0K | -99.7% |
| 2022 | $46.27M | -58.8% |
| 2021 | $112.40M | +14.2% |
| 2020 | $98.44M | +90.6% |
| 2019 | $51.65M | +41.9% |
| 2018 | $36.40M | -39.2% |
| 2017 | $59.83M | +146.5% |
| 2016 | $24.28M | +687.9% |
| 2015 | -$4.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.77M | +212.9% | +237.9% |
| June 30, 2025 | $2.89M | +134.7% | -19.9% |
| March 31, 2025 | $3.61M | +173.0% | +193.2% |
| December 31, 2024 | -$3.87M | -3248.8% | +55.3% |
| September 30, 2024 | -$8.66M | -315.9% | -3.9% |
| June 30, 2024 | -$8.33M | -160.7% | -68.5% |
| March 31, 2024 | -$4.94M | -116.6% | -4118.7% |
| December 31, 2023 | $123.0K | -99.7% | -96.9% |
- MUSTANG BIO, INC. showed an increase of +346.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, MUSTANG BIO, INC.’s stockholders equity has grown by 330.8% (from -$4.13 million to $9.53 million).
- The most recent figure is from MUSTANG BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: